William Rose
Président chez Greenhill School
Profil
William Edward Rose is currently the Chairman at Greenhill School.
He previously worked as a Managing Director at HBK Investments LP, a Director at Impac Mortgage Holdings, Inc., and as the President of Montrose Capital, Inc. He also served as an Independent Director at Reata Pharmaceuticals, Inc. from 2016 to 2023.
Mr. Rose received his undergraduate degree from Duke University in 1989.
Postes actifs de William Rose
| Sociétés | Poste | Début |
|---|---|---|
| Greenhill School | Président | - |
Anciens postes connus de William Rose
| Sociétés | Poste | Fin |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 26/09/2023 |
| Montrose Capital, Inc. | President | - |
HBK Investments LP
 HBK Investments LP Investment ManagersFinance HBK Investments LP, do-business-as HBK Capital Management (HBK), is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. The firm was founded in 1991 and is a subsidiary of HBK Partners II LP. HBK provides discretionary investment management services and related administrative services to their funds, which are private investment funds offered only to sophisticated investors with substantial resources. | Directeur en chef des Investissements | - |
| IMPAC MORTGAGE HOLDINGS, INC. | Directeur/Membre du Conseil | - |
Formation de William Rose
| Duke University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMPAC MORTGAGE HOLDINGS, INC. | Finance |
| Entreprise privées | 3 |
|---|---|
HBK Investments LP
HBK Investments LP Investment ManagersFinance HBK Investments LP, do-business-as HBK Capital Management (HBK), is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. The firm was founded in 1991 and is a subsidiary of HBK Partners II LP. HBK provides discretionary investment management services and related administrative services to their funds, which are private investment funds offered only to sophisticated investors with substantial resources. | Finance |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
| Montrose Capital, Inc. |
